Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fisher Biosciences was a prominent life sciences division of Fisher Scientific International, specializing in the development and manufacture of reagents, consumables, and equipment for biological research. The company was formed through the strategic consolidation of industry-leading brands such as Dharmacon, HyClone, Pierce Biotechnology, and Abgene. Its product portfolio was essential for researchers working in genomics, proteomics, and cell culture, providing tools for RNA interference, protein purification, and specialized media. In 2006, Fisher Scientific merged with Thermo Electron to form Thermo Fisher Scientific, at which point Fisher Biosciences was integrated into the new organization's Analytical Technologies and Laboratory Products segments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fisher Biosciences.